drugset / Trial / NCT00423891
A Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus (HBV)-Infection
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this clinical study is to determine the appropriate doses of entecavir to use in children and adolescents. Safety, tolerability and efficacy will also be studied
Timeline
- Start
- 2007-06-30
- Primary completion
- 2013-08-31
- Completion
- 2017-09-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Entecavir | Small molecule | 0.015 mg/kg | Oral |
| Subject | Entecavir | Small molecule | 0.03 mg/kg | Oral |